Sotac Pharma.
Minerva Ventures Fund reduced its stake in Sotac Pharma from 1.64% to 1.60%, selling 4,800 shares.
A pharmaceutical manufacturer operating in India, Sotac Pharma produces and distributes a comprehensive range of pharmaceutical products across multiple therapeutic categories and treatment areas. Founded in 2015, the company engages in formulation development, active pharmaceutical ingredient sourcing, manufacturing operations, and distribution of medicines. It serves both domestic Indian markets and international customers through its established supply chains and regulatory compliance frameworks.
A Mauritius-based foreign portfolio investor and an active anchor investor in Indian SME public issues, where it has backed a steady run of listings. It also builds positions in listed small caps. The fund reports through more than one vehicle, including an Indus QRAC strategy, and both sit under the same administrator.